| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-06 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |